RxDoctor Payments Data

Kyung Park, MD

Anatomic Pathology & Clinical Pathology · Stamford, CTNPI 1194083154

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,240 of the $1,300 with a category attached, or 95.4%. AstraZeneca accounts for 95.4% of it on its own, with 1 other manufacturer making up the rest.

$1,300in general payments, 2019–2025

Across 3 payments — averaging $433.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Atricure, Inc.$60
$169,338in research payments, 2019–2025

Across 1 payment — averaging $169,338 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$169K

What the payments were for

  • Consulting fees$1,24095%
  • Food & beverage$605%

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$1,240
Atricure, Inc.2$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,300 in reported general payments places this provider in the 85th percentile of 94 anatomic pathology & clinical pathology providers in Connecticut.

See all anatomic pathology & clinical pathology providers in Connecticut

Medicare billing

Part B allowed, 2024
$49,088
Medicare patients
522
Services billed
818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →